149 related articles for article (PubMed ID: 17914405)
1. Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases.
Stieger K; Mendes-Madeira A; Meur GL; Weber M; Deschamps JY; Nivard D; Provost N; Moullier P; Rolling F
Gene Ther; 2007 Dec; 14(23):1668-73. PubMed ID: 17914405
[TBL] [Abstract][Full Text] [Related]
2. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors.
Stieger K; Le Meur G; Lasne F; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Martin L; Moullier P; Rolling F
Mol Ther; 2006 May; 13(5):967-75. PubMed ID: 16442848
[TBL] [Abstract][Full Text] [Related]
3. Sustained tetracycline-regulated transgene expression in vivo in rat retinal ganglion cells using a single type 2 adeno-associated viral vector.
Folliot S; Briot D; Conrath H; Provost N; Cherel Y; Moullier P; Rolling F
J Gene Med; 2003 Jun; 5(6):493-501. PubMed ID: 12797114
[TBL] [Abstract][Full Text] [Related]
4. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR.
Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC
Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187
[TBL] [Abstract][Full Text] [Related]
5. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
Rolling F
Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
[TBL] [Abstract][Full Text] [Related]
6. Stable rAAV-mediated transduction of rod and cone photoreceptors in the canine retina.
Bainbridge JW; Mistry A; Schlichtenbrede FC; Smith A; Broderick C; De Alwis M; Georgiadis A; Taylor PM; Squires M; Sethi C; Charteris D; Thrasher AJ; Sargan D; Ali RR
Gene Ther; 2003 Aug; 10(16):1336-44. PubMed ID: 12883530
[TBL] [Abstract][Full Text] [Related]
7. Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats.
Ikeda Y; Goto Y; Yonemitsu Y; Miyazaki M; Sakamoto T; Ishibashi T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K
Gene Ther; 2003 Jul; 10(14):1161-9. PubMed ID: 12833125
[TBL] [Abstract][Full Text] [Related]
8. AAV-mediated gene therapy for retinal disorders: from mouse to man.
Buch PK; Bainbridge JW; Ali RR
Gene Ther; 2008 Jun; 15(11):849-57. PubMed ID: 18418417
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands.
Wang J; Voutetakis A; Papa M; Rivera VM; Clackson T; Lodde BM; Mineshiba F; Baum BJ
Gene Ther; 2006 Jan; 13(2):187-90. PubMed ID: 16177817
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for ocular angiogenesis.
Bainbridge JW; Mistry AR; Thrasher AJ; Ali RR
Clin Sci (Lond); 2003 Jun; 104(6):561-75. PubMed ID: 12570869
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo.
Koponen JK; Kankkonen H; Kannasto J; Wirth T; Hillen W; Bujard H; Ylä-Herttuala S
Gene Ther; 2003 Mar; 10(6):459-66. PubMed ID: 12621450
[TBL] [Abstract][Full Text] [Related]
12. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.
Favre D; Blouin V; Provost N; Spisek R; Porrot F; Bohl D; Marmé F; Chérel Y; Salvetti A; Hurtrel B; Heard JM; Rivière Y; Moullier P
J Virol; 2002 Nov; 76(22):11605-11. PubMed ID: 12388721
[TBL] [Abstract][Full Text] [Related]
13. Acute toxicity study of a simian immunodeficiency virus-based lentiviral vector for retinal gene transfer in nonhuman primates.
Ikeda Y; Yonemitsu Y; Miyazaki M; Kohno R; Murakami Y; Murata T; Goto Y; Tabata T; Ueda Y; Ono F; Suzuki T; Ageyama N; Terao K; Hasegawa M; Sueishi K; Ishibashi T
Hum Gene Ther; 2009 Sep; 20(9):943-54. PubMed ID: 19416079
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated virus mediated gene therapy for retinal degenerative diseases.
Stieger K; Cronin T; Bennett J; Rolling F
Methods Mol Biol; 2011; 807():179-218. PubMed ID: 22034031
[TBL] [Abstract][Full Text] [Related]
15. [The treatment of inherited dystrophies and neovascular disorders of the retina by rAAV-mediated gene therapy].
Stieger K; Lorenz B
Klin Monbl Augenheilkd; 2008 Dec; 225(12):1009-23. PubMed ID: 19085778
[TBL] [Abstract][Full Text] [Related]
16. Topical doxycycline can induce expression of BDNF in transduced retinal pigment epithelial cells transplanted into the subretinal space.
Abe T; Wakusawa R; Seto H; Asai N; Saito T; Nishida K
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3631-9. PubMed ID: 18660427
[TBL] [Abstract][Full Text] [Related]
17. Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain.
Fitzsimons HL; Mckenzie JM; During MJ
Gene Ther; 2001 Nov; 8(22):1675-81. PubMed ID: 11892834
[TBL] [Abstract][Full Text] [Related]
18. [The development in the studies of AAV-mediated gene therapy in retina].
Zou X; Sui RF; Dong FT
Zhonghua Yan Ke Za Zhi; 2011 Nov; 47(11):1049-52. PubMed ID: 22336072
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
Pechan P; Rubin H; Lukason M; Ardinger J; DuFresne E; Hauswirth WW; Wadsworth SC; Scaria A
Gene Ther; 2009 Jan; 16(1):10-6. PubMed ID: 18633446
[TBL] [Abstract][Full Text] [Related]
20. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
